ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,960Medicare Part D Prescriptions Filled, Including Refills

Rank: 109 out of 617

$473K Total Retail Price of All Prescriptions

Rank: 113 out of 617

437 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 437 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

3% of this provider’s 437 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 6,640 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
FUROSEMIDE 387 353 1 4
LEVOTHYROXINE SODIUM 376 205 2 1
OMEPRAZOLE 358 214 3 3
SIMVASTATIN 291 238 4 2
WARFARIN SODIUM 273 215 5 7
AMLODIPINE BESYLATE 264 217 6 6
POTASSIUM CHLORIDE 256 206 7 10
LISINOPRIL 223 181 8 5
GABAPENTIN 211 166 9 16
METFORMIN HCL 200 134 10 9
POLYETHYLENE GLYCOL 3350 172 50 11 32
METOPROLOL SUCCINATE 168 155 12 12
FAMOTIDINE 163 100 13 54
TRAMADOL HCL 152 135 14 15
TAMSULOSIN HCL 143 128 15 26
SERTRALINE HCL 135 118 16 20
OLANZAPINE 118 35 17 139
RISPERIDONE 113 32 18 71
ATENOLOL 113 100 18 17
VENLAFAXINE HCL ER 109 29 20 76
ALENDRONATE SODIUM 108 82 21 25
MELOXICAM 107 87 22 24
CARBAMAZEPINE 106 0 23 185
ATORVASTATIN CALCIUM 98 76 24 14
ACTOS 92 67 25 85
CEPHALEXIN 89 60 26 68
LISINOPRIL-HYDROCHLOROTHIAZIDE 87 87 27 29
PREDNISONE 87 69 27 31
BENZTROPINE MESYLATE 84 28 R 29 163
METOPROLOL TARTRATE 80 75 30 11
CELEBREX 79 78 31 63
FLUVOXAMINE MALEATE 77 0 32 266
DIVALPROEX SODIUM 74 12 33 111
HALOPERIDOL 74 22 33 230
HYDROCHLOROTHIAZIDE 72 59 35 13
KETOCONAZOLE 72 15 35 231
PHENYTOIN SODIUM EXTENDED 71 0 37 121
FLUTICASONE PROPIONATE 69 20 38 36
DILANTIN 69 0 38 239
CARVEDILOL 64 63 40 19
LOSARTAN-HYDROCHLOROTHIAZIDE 63 61 41 46
TRIAMTERENE-HCTZ 59 53 42 47
DIGOXIN 57 56 43 48
CYCLOBENZAPRINE HCL 56 0 R 44 74
ALLOPURINOL 54 43 45 27
DIVALPROEX SODIUM ER 52 24 46 181
QUETIAPINE FUMARATE 51 29 47 78
AMITRIPTYLINE HCL 50 17 R 48 56
CLOTRIMAZOLE-BETAMETHASONE 50 32 48 175
HYDROCODONE-ACETAMINOPHEN 50 33 S3 48 8
LOSARTAN POTASSIUM 50 50 48 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 7, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.